| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a4afad3e494b346d858b4347aac9209d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_be79f9adad5a024cc5afa9d5361a3cea
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9c004af0122aff8a55f96d2e53889f96
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a634c06196f5da3ad34f774d8a6923ec |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-323
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-2871
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-065
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-765
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-325 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6896 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-566
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B- |
| filingDate |
2002-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e1d23805b6713168367650e75b3d6c1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_64f561dc661f075c9aed148b002b412a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_08357182d0087efab8acd2900d205837 |
| publicationDate |
2004-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2004054431-A2 |
| titleOfInvention |
Tests for the rapid evaluation of ischemic states and kits |
| abstract |
The present invention relates to rapid methods for the detection of ischemic states and to kits for use in such methods. Provided for is a rapid method of testing for and quantifying ischemia based upon methods of detecting and quantifying the existence of an alteration of the serum protein albumin which occurs following an ischemic event; methods for detecting and quantifying this alteration include evaluating and quantifying the cobalt binding capacity of circulating albumin, analysis and measurement of the ability of serum albumin to bind exogenous cobalt, detection and measurement of the presence of endogenous copper in a purified albumin sample and use of an immunological assay specific to the altered form of serum albumin which occurs following an ischemic event. Also taught by the present invention is the detection and measurement of an ischemic event by measuring albumin N-terminal derivatives that arise following an ischemic event, including truncated albumin species lacking one to four N-terminal amino acids or albumin with an acetylated N-terminal Asp residue. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105395188-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1857818-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7074194-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7063782-B2 |
| priorityDate |
2002-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |